Messages in brief
Deactivation of the e-mail address "spc-vete@ages.at" for veterinary medicines
messages in brief
|
17/04/2014
Austrian "Summaries of Product Characteristics", "Labellings" and "Patient Information Leaflets" should now be submitted via PHAROS eService…
Deactivation of the e-mail address "spc-vete@ages.at" for veterinary medicines
Read more
Counterfeit Herceptin (trastuzumab)
Safety warnings
|
messages in brief
|
16/04/2014
European Medicines Agency warns against counterfeit Herceptin
Counterfeit Herceptin (trastuzumab)
Read more
Protelos/Osseor
Safety warnings
|
messages in brief
|
21/02/2014
European Medicines Agency recommends restriction of use of Protelos/Osseor
Protelos/Osseor
Read more
Important information about differences in thromboembolism risk of combined oral contraceptives.
Safety warnings
|
messages in brief
|
03/02/2014
Prescription of CHCs and importance of individual risk factors.
Important information about differences in thromboembolism risk of combined oral contraceptives.
Read more
Re-evaluation of the effectiveness of emergency contraception "morning-after pill" started
Safety warnings
|
messages in brief
|
24/01/2014
Re-evaluation with regard to higher body weight or BMI
Re-evaluation of the effectiveness of emergency contraception "morning-after pill" started
Read more
Incorrect use of Eldisin 5 mg dry vial (Vindesin Sulfate).
Safety warnings
|
messages in brief
|
20/12/2013
The preparation Eldisin 5 mg dry ampoules (active ingredient: vindesine sulfate) has been approved in Austria since March 29, 1984. Vindesine is a…
BASG statement
messages in brief
|
07/10/2013
Policy 0070 on publication and access to clinical-trial data
BASG statement
Read more
Federal Office for Safety in Health Care
messages in brief
|
07/10/2013
New management of AGES Medical Market Surveillance
Federal Office for Safety in Health Care
Read more
What does the black triangle mean?
messages in brief
|
03/10/2013
The European Union has introduced a new labeling for medicinal products that are subject to particularly close monitoring.
These medicines are…
Extension of the usability of drug stocks
messages in brief
|
01/10/2013
Many medicinal products, when stored appropriately, remain in compliance with their specifications for much longer than can be expected on the basis…
